Digital Health
David Novillo Ortiz, head of data and digital health at the World Health Organization, discusses the objectives of WHO's regional digital health action plan and assessing the plan's impact in improving patient access and engagement.
Dr. Mohamed Rehman, chair of the department of anesthesia at Johns Hopkins All Children's Hospital, talks about digital twin adoption and data aggregation to create a digital copy of an individual for personalized medicine.
Abigail Norville, deputy secretary general at the Ministry of Health, Welfare and Sport in the Netherlands, tells why involving all healthcare stakeholders in forming care's evolution is vital, especially regarding digitization and innovation.
Dr. Alan Spiro, president and CMO of Laguna Health, highlights the findings of recently published research on post-acute hospitalization recovery, the factors associated with readmission and digital health's role in home health maintenance.
Munjal Shah, CEO and cofounder of Hippocratic AI, shares the difference between his company's large language model and Google and ChatGPT's LLMs – and the benefit of partnering with health systems while developing the model to ensure efficacy.
Petra Hoogendoorn, coordinator of EU project Label2Enable, talks about designing labels for healthcare-related apps to ensure clarity and safety for all stakeholders and discusses the project’s work within Europe, the U.S. and beyond.
Anna Dover, director of product management at FDB, formerly First Data Bank, says drug-related clinical decision support alerts pose challenges for prescribers and pharmacists, but technology can optimize the process through refinement.
Dr. John B. Halamka, president of Mayo Clinic Platform, discusses AI's "dizzying" evolution, Mayo’s strategy for approaching predictive AI versus generative AI, and its partnership with Google that practices agile development of AI.
Amir Bozorgzadeh, cofounder and CEO of Virtuleap, which combines neuroscience and virtual reality for brain training, discusses a partnership with Roche to screen for precursors of cognitive impairment.
HIMSS23
Freddie Feldman, director of voice and conversational interfaces at Wolters Kluwer, talks about the potential of using AI and natural language processing for voice interfaces, and about limitations in the answers that generative AI can provide.